In article in New England Journal of Medicine, Dr. Philip L. McCarthy and co-authors report significant time-to-progression benefit as well as survival benefit for patients who took maintenance doses of lenalidomide following stem-cell transplant.
Vatican Radio tackles organ harvesting in light of questionable 'brain death … – Lifesite
LifesiteVatican Radio tackles organ harvesting in light of questionable 'brain death …Lifesiteby Thaddeus Baklinski ROME, May 9, 2012 (LifeSiteNews.com) – The controversy surrounding the questionable criterion of 'brain death' used to det…
New Drug Shows Promise for Myeloma Patients – MSN Health & Fitness
New Drug Shows Promise for Myeloma PatientsMSN Health & FitnessIn younger people, the standard treatment is generally a stem cell transplant to replace the many of the cancerous plasma cells. However, many older patients are ineligible for this treatme…
Area Teen Put on Heart Transplant List
An area boy, born with a severe heart defect has received some great news.
CHOP-RIT, CHOP-R Similar for Follicular Lymphomas – Clinical Oncology News
Clinical Oncology NewsCHOP-RIT, CHOP-R Similar for Follicular LymphomasClinical Oncology NewsSan Diego—Radiolabeled iodine-131 tositumomab (RIT) and rituximab have similar efficacy and tolerability when either is combined with CHOP (cyclophosphamide,…
Gene-modified stem cell transplant protects patients from toxic side effects … – Science Codex
Gene-modified stem cell transplant protects patients from toxic side effects …Science CodexAs many as 50 percent to 60 percent of glioblastoma patients harbor such chemotherapy-resistant tumors, which makes gene-modified stem cell transplant therapy …
State blamed for illicit organ trade – Deccan Chronicle
State blamed for illicit organ tradeDeccan Chronicle… ISOT pointed out loopholes in the Human Organ Transplantation Act, lack of stringent punishment, monitoring and delay in implementation of Jeevandan programme that entailed setting up of brain-dea…
Gene-modified stem cell transplant protects patients from toxic side effects of chemotherapy
( Fred Hutchinson Cancer Research Center ) For the first time, scientists at Fred Hutchinson Cancer Research Center have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic …
Procedure offers hope in type 1 diabetes
New strategy proves curative in more than half of mice tested
Transplanted Gene-Modified Blood Stem Cells Protect Brain Cancer Patients From Toxic Side Effects of Chemotherapy
For the first time, scientists at Fred Hutchinson Cancer Research Center have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic side effects of chemotherapy. Initial resul…